• Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio
  • Team
  • Insights
    • Blog: Rock Island Review
    • News & Announcements
Menu
  • Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio
  • Team
  • Insights
    • Blog: Rock Island Review
    • News & Announcements
Ti-linkedin
News

MorphImmune, Inc., a Research Bridge Partners Portfolio Company, Appoints Ronald Martell as President and CEO

— The former President and CEO of Nuvelution Pharma also served as the CEO of three public biopharmaceutical companies, including Sevion and […]

Ryan FieldJune 8, 2021
News

Research Bridge Partners’ Portfolio Company, Novosteo, Inc., Closes $5.5 Million in Series A Financing

– The Purdue University Spinout’s NOV004, the first-ever targeted bone anabolic agent, has shown promise in accelerating fracture healing –  AUSTIN, Texas, […]

Ryan FieldMarch 16, 2021
News

Research Bridge Partners’ Seed Capital Investment in Asalyxa Bio Advances Dr. Lola Eniola-Adefeso’s Immune Cell Targeted Therapeutic Platform

— University of Michigan BioInterfaces Institute spinout has developed a technology to treat a wide range of life-threatening inflammatory diseases, including Acute […]

Ryan FieldMarch 9, 2021
News

Research Bridge Partners Makes Seed Capital Investment In Erisyon, Inc.

— University of Texas spinout is developing world’s first single-molecule protein sequencing platform — AUSTIN, TX (November 30, 2020) – Research Bridge […]

Ryan FieldNovember 30, 2020
News

Research Bridge Partners Makes Seed Investment in Eradivir, Inc.

AUSTIN, Texas, April 15, 2020 /PRNewswire/ -- Research Bridge Partners—a not-for-profit that enhances the societal and economic returns on America's investment in research universities by bridging mid-continent university innovators and commercialization resources nationally—announced the investment of seed capital in Eradivir, Inc.

Ryan FieldApril 15, 2020
News

Research Bridge Partners Makes Seed Capital Investment In Novosteo, Inc.

Research Bridge Partners—a not-for-profit that enhances the societal and economic returns on America's investment in research universities by bridging mid-continent university innovators and commercialization resources nationally—announced the investment of seed capital in Novosteo, Inc.

Ryan FieldAugust 8, 2019
News

Research Bridge Partners Launches Seed Fund To Catalyze Commercialization Of Mid-Continent Research

AUSTIN, Texas, July 16, 2019 -- Research Bridge Partners—a not-for-profit that enhances the societal and economic returns on America's investment in research universities by bridging mid-continent university innovators and commercialization resources nationally—has launched a program-related investment (PRI) seed fund to invest in promising university spinouts.

Ryan FieldJuly 16, 2019

About

  • Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio
Menu
  • Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio

Insights

  • Rock Island Review
  • News & Announcements
Menu
  • Rock Island Review
  • News & Announcements

Company

  • Team
  • Contact
Menu
  • Team
  • Contact

Connect

Linkedin-in

© 2023 Research Bridge Partners. All rights reserved

 Twitter
 LinkedIn
 Email